(-0.07%) 5 465.35 points
(-0.06%) 39 087 points
(0.18%) 17 749 points
(-0.61%) $80.34
(-4.32%) $2.64
(-0.86%) $2 310.70
(-0.05%) $28.86
(2.30%) $1 009.10
(0.30%) $0.936
(0.73%) $10.68
(0.49%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases...
Stats | |
---|---|
Today's Volume | 15 716 |
Average Volume | 4 938 |
Market Cap | 1.72B |
EPS | $-1.140 ( Q1 | 2024-05-08 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.332 (3.52%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-04 | Lewis William | Buy | 100 000 | Option (right to buy) |
2024-01-04 | Lewis William | Buy | 0 | |
2024-01-01 | Kooij Louise Frederika | Buy | 150 494 | Option (right to buy) |
2024-01-01 | Kling Douglas F | Buy | 323 771 | Option (right to buy) |
2024-01-01 | Van Der Kamp Hilde Johanna | Buy | 10 000 | Option (right to buy) |
INSIDER POWER |
---|
-60.42 |
Last 28 transactions |
Buy: 2 224 204 | Sell: 9 064 754 |
NewAmsterdam Pharma Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
NewAmsterdam Pharma Financials
Annual | 2023 |
Revenue: | $14.09M |
Gross Profit: | $14.05M (99.68 %) |
EPS: | $-2.15 |
FY | 2023 |
Revenue: | $14.09M |
Gross Profit: | $14.05M (99.68 %) |
EPS: | $-2.15 |
FY | 2022 |
Revenue: | $97.50M |
Gross Profit: | $97.43M (99.93 %) |
EPS: | $-7.85 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
NewAmsterdam Pharma
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein cholesterol (HDL-C). The company was founded in 2019 and is based in Naarden, the Netherlands.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators